发明名称 |
Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 |
摘要 |
A combination of temsirolimus and trastuzumab in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of a trastuzumab and a HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing trastuzumab, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described. |
申请公布号 |
US2012308560(A1) |
申请公布日期 |
2012.12.06 |
申请号 |
US201213454768 |
申请日期 |
2012.04.24 |
申请人 |
MOORE LAURENCE;ZACHARCHUK CHARLES;RABINDRAN SRIDHAR K.;WYETH LLC |
发明人 |
MOORE LAURENCE;ZACHARCHUK CHARLES;RABINDRAN SRIDHAR K. |
分类号 |
A61K39/395;A61P35/00;A61P35/04 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|